SCHEMBL23336506

SCHEMBL23336506

CC(C)=CC(=O)Nc1ccc(C(=O)NF)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 7/20 0.60
▸ RAB9A P51151 7/20 0.60
▸ SMN1; SMN2 Q16637 5/20 0.60
▸ TSHR P16473 1/20 0.60
▸ NFKB1 P19838 1/20 0.60
▸ NFKB2 Q00653 1/20 0.60
▸ RELA Q04206 1/20 0.60
▸ GAA P10253 1/20 0.60
▸ HTT P42858 1/20 0.60
▸ MEN1 O00255 2/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ CASP3 P42574 1/20 0.47
▸ SENP8 Q96LD8 1/20 0.47
▸ SENP7 Q9BQF6 1/20 0.47
▸ SENP6 Q9GZR1 1/20 0.47
▸ GPR55 Q9Y2T6 1/20 0.47
▸ TP53 P04637 3/20 0.47
▸ PKM P14618 2/20 0.46
▸ HPGD P15428 1/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20691197 0.85 SMN1; SMN2 (0.62) NPC1RAB9ASMN1; SMN2TSHRNFKB1
SCHEMBL11759969 0.82 SMN1; SMN2 (0.68) NPC1RAB9ASMN1; SMN2TSHRNFKB1
SCHEMBL5645657 0.79 SMN1; SMN2 (0.68) NPC1RAB9ASMN1; SMN2TSHRNFKB1
SCHEMBL3713301 0.77 NPC1 (0.70) NPC1RAB9ASMN1; SMN2TSHRNFKB1
SCHEMBL20284039 0.77 NPC1 (0.70) NPC1RAB9ASMN1; SMN2TSHRNFKB1
SCHEMBL4135335 0.75 NPC1 (1.00) NPC1RAB9ASMN1; SMN2TSHRNFKB1
SCHEMBL17675351 0.75 SMN1; SMN2 (0.68) NPC1RAB9ASMN1; SMN2TSHRNFKB1
SCHEMBL2998577 0.75 SMN1; SMN2 (1.00) NPC1RAB9ASMN1; SMN2TSHRNFKB1
SCHEMBL7679084 0.74 SMN1; SMN2 (0.67) NPC1RAB9ASMN1; SMN2TSHRNFKB1
SCHEMBL396577 0.74 SMN1; SMN2 (0.67) NPC1RAB9ASMN1; SMN2TSHRNFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3057956-B1 POLYCYCLIC INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) DANA FARBER CANCER INST INC (US) 2021-05-05 — — EP disclosed
Send feedback